Multicenter prospective study on the changes of sexual function following treatment with alfuzosin (Xatral XL) in patients with benign prostatic hypertrophy.
Phase of Trial: Phase IV
Latest Information Update: 15 Mar 2010
At a glance
- Drugs Alfuzosin (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- Sponsors Sanofi
- 24 Oct 2007 New trial record.